Magdalena Ciążyńska

13PUBLICATIONS
15CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityMolecular targetsInnate immunityPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 27, 2026
Beyond Hematology-Current Insights into Chimeric Antigen Receptor (CAR) T-Cell Therapy for Skin and Connective Tissue Disorders.

|Feb 13, 2026
Primary Cutaneous B-Cell Lymphoma Imitating Pyoderma Gangrenosum: A Rare and Complex Diagnostic Challenge.

Maria Markowska, Łukasz Chętko, Natalia Bień

|Nov 27, 2025
Immune Checkpoint Blockade Therapy for Advanced Cutaneous Squamous Cell Carcinoma in Immunosuppressed Patients, Transplant Recipients, and Individuals with Hereditary Syndromes: A Narrative Review.

Marta Pabianek, Aleksandra Lesiak, Joanna Narbutt

|Jun 26, 2025
Targeting Biomarkers of Proliferation and Inflammation (Ki67, p53, and COX-2) in Actinic Keratoses with Photodynamic Therapy.

Justyna Ceryn, Aleksandra Lesiak, Magdalena Ciążyńska

|Feb 26, 2025
Mechanisms of Resistance to Anti-PD-1 Immunotherapy in Melanoma and Strategies to Overcome It.

Magdalena K Zielińska, Magdalena Ciążyńska, Dorota Sulejczak

|Aug 26, 2022
The Kinetics of FMS-Related Tyrosine Kinase 3 Ligand (Flt-3L) during Chemoradiotherapy Suggests a Potential Gain from the Earlier Initiation of Immunotherapy.

Łukasz Kuncman, Magdalena Orzechowska, Konrad Stawiski

Pageof 3

Frequent Collaborators

1 joint publications

Michał Waszczykowski

1 joint publications

Izabela Dróżdż

1 joint publications

Łukasz Kuncman

1 joint publications

Magdalena Orzechowska